logo

Trastunix

Trastunix 440 mg injection is a HER2/neu receptor antagonist indicated for the treatment of HER2 overexpressing breast cancer and the treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma


Features

Product Name Trastunix
Generic Name Trastuzumab
Therapeutic Class Monoclonal antibody
Formulation Lyophilized Powder for Injection
Available Pack Size 1x1
Available Strength 440 mg
Download Prescribing Information Visit Website